Home Science MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapyTechScienceMDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapyAugust 15, 2019116FacebookTwitterPinterestWhatsApp A study has identified a possible second-line treatment for melanoma patients.Source: ScienceDaily.com